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2-Bromopropane (2-BP), a cleaning agent, is used as an alternative to ozone-depleting solvents. 
Previously, 2-BP was shown to have cytotoxic effects on mouse blastocysts and is associated with 
defects in their subsequent development, both in vitro and in vivo. In addition, it was found that 2-BP 
also has cytotoxic effects on oocyte maturation and subsequent pre- and post implantation 
development in vitro and in vivo, and significantly reduces the rate of oocyte maturation, fertilization, 
and embryonic development in vitro. This study shows that 2-BP (5 to 10 μM) induces apoptotic 
processes in mouse embryonic stem cells (ESC-B5), but exerts no effects at treatment dosages below 5 
μM. In ESC-B5 cells, 2-BP directly increased the content of reactive oxygen species (ROS), significantly 
increased the cytoplasmic free calcium and nitric oxide (NO) levels, triggered a loss of mitochondrial 
membrane potential (MMP), activated caspases-9 and -3, and induced cell death. Pre-treatment with NO 
scavengers suppressed the apoptotic biochemical changes induced by 10 μM 2-BP and promoted the 
gene expression levels of p53 and p21, which are involved in apoptotic signaling. These results 
demonstrate for the first time that 2-BP triggers apoptosis in mouse embryonic stem cells via ROS, NO 
and the activation of mitochondria-dependent cell death signaling. 
 





2-Bromopropane (2-BP), a cleaning agent, is used as an 
alternative to ozone-depleting solvents. In 1995, 2-BP 
was shown to have caused a series of reproductive and 
hematopoietic disorders in female and male workers 
commonly exposed to the solvent in an electronics 
factory located in South Korea (Kim et al., 1996; Park et 
al., 1997). Moreover, earlier reports found a high 
incidence of oligozoospermia in male workers after long-
term exposure to 2-BP (Kim et al., 1996; Li et al., 2001; 
Park et al., 1997). Several animal studies have further 
confirmed the potential of 2-BP to affect the reproductive, 
hematopoietic, central nervous and immune systems 
(Ichihara et al., 1997; Kim et al., 2004; Omura et al., 
1999; Son et al., 1999; Wu et al., 2002; Yu et al., 1999a; 
Yu et al., 1999b; Zhao et al., 2002). In cytotoxicity 
experiments, mouse embryos treated with 2-BP formed 
micronuclei and shows a decrease in embryonic cell 
numbers (Ishikawa et al., 2001). Moreover, 2-BP was 
recently identified as a potent DNA damaging agent (Wu 
et al., 2002; Zhao et al., 2002). These results collectively 
suggest that 2-BP induces various toxicities via DNA 
damage. A reproductive toxicity investigation further 
demonstrates that exposure to 2-BP induced testicular or 
ovarian dysfunction, causes injury to early types of 
spermatogenic cells or primordial follicles and oocytes in 
rats (Omura et al., 1999; Yu et al., 1999b).  
In an experiment investigating the effects of 2-BP on 
pre- and postnatal development, exposure of pregnant or 
lactating female rats to 2-BP results in a decreased 
delivery rate, increase in pre- and postnatal death,
  






decreased body weight, and a higher incidence of 
reproductive organ dysfunction (Kang et al., 2002). To 
date, however, no clinical study, epidemiological study or 
case report has demonstrated a direct relationship 
between reproductive problems and the exposure of 
pregnant workers to 2-BP. Specifically, there is no 
evidence to suggest that the solvent negatively affects 
embryonic development or infant growth in humans. 
However, it is very important to explore the health risks 
associated with the exposure of female workers, 
especially those who are pregnant, to 2-BP.  
Importantly, the solvent is very volatile and can 
permeate human skin. The major exposure route is via 
inhalation in the workplace or factory (Kim et al., 1996; 
Park et al., 1997). Moreover, recent study by our group 
shows that 2-BP induces cellular apoptosis in both the 
inner cell mass (ICM) and trophectoderm cells (TE) of 
mouse blastocysts, leading to decreased implantation, 
reduced embryonic development, and a loss of 
embryonic viability (Chan, 2010a). Notably, it was further 
discovered that 2-BP significantly reduced the rates of 
oocyte maturation, fertilization, and in vitro embryonic 
development (Chan, 2010b). These results clearly 
indicate that 2-BP may be a serious risk factor that affects 
both the pre- and post-implantation stages of embryonic 
development. However, the precise regulatory mecha-
nisms underlying the potentially adverse effects of 2-BP 
on early embryonic development require further 
investigation.  
Numerous chemical and physical treatments capable of 
inducing apoptosis stimulate oxidative stress via the 
generation of reactive oxygen species (ROS) in cells 
(Khan et al., 2013; Rhee et al., 2013), suggesting that 
there is a close relationship between oxidative stress and 
apoptosis. Nitric oxide (NO) is an important second 
messenger involved in a variety of cellular responses and 
biological functions, including tumor development, 
metastasis and apoptosis (Kruzliak et al., 2013; Sun et 
al., 2013). Recent studies have demonstrated that NO is 
predominantly produced in mitochondria through the 
actions of a Ca
2+
-sensitive mitochondrial NO synthase 
(NOS) (Lu et al., 2006; Nazarewicz et al., 2007). NOS-
mediated NO production may regulate oxygen con-
sumption and mitochondrial membrane potential through 
cytochrome c oxidase.  
The NO molecule is subsequently reactivated with 
superoxide to produce peroxynitrite, leading to further 
modification of its target substrates and induction of 
oxidative stress (Brookes, 2004; Dennis and Bennett, 
2003; Ghafourifar and Cadenas, 2005; Wang et al., 
2013). Oxidative stress and changes in intracellular Ca
2+
 
act as upstream regulators of mitochondrial NOS activity 
(Dedkova et al., 2004; Elfering et al., 2002), and we 
recently showed that changes in intracellular Ca
2+
 were 
significantly involved in ROS generation-triggered cell 
apoptosis ESC-B5 cells(Chan et al., 2013).     




Embryonic stem cells (ESCs) are pluripotent, early 
embryo-derived cells.  When  cultured in the  presence of 
anti-differentiation agents, such as embryonic fibroblasts 
or leukemia inhibitory factor (LIF), ESCs proliferate while 
maintaining their capacity to differentiate into any cell 
type in the body (Evans and Kaufman, 1981). When the 
anti-differentiation agent is withdrawn, ESCs 
spontaneously differentiate and develop in a manner that 
recapitulates early embryogenesis (Keller, 1995). 
Following differentiation in suspension culture, ESCs 
typically form three-dimensional aggregates known as 
embryoid bodies (EBs), which consist of ectodermal, 
mesodermal and endodermal tissues resembling the egg-
cylinder stage of embryos. In view of these properties, EB 
formation is a useful in vitro system for analyzing early 
embryonic development and differentiation processes. 
To elucidate the precise regulatory mechanisms of 2-
BP-triggered cytotoxicity in mouse ESCs, the effects of 2-
BP on ESC-B5 cells is examined, and herein propose a 
model for 2-BP-induced cell injury signaling in mouse 
ESCs. Our results reveal for the first time that 2-BP 
treatment triggers apoptosis in mouse ESCs via ROS- 
and NO-related mitochondria-dependent apoptotic 




MATERIALS AND METHODS 
 
Chemicals and reagents 
 
2-Bromopropane, 3-(4, 5-dimethylthiazol-2-yl)- 2,5-
diphenyltetrazolium bromide (MTT), Dulbecco's modified Eagle's 
medium (DMEM), sodium pyruvate, 2’,7’-dichlorofluorescin 
diacetate (DCF-DA), dihydrorhodamine 123 (DHR 123), 2-phenyl- 
4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (PTIO), N-acetyl 
cysteine (NAC), 2’,7’-dichlorofluorescein diacetate (DCF-DA), 
propidium iodide, Hoechst 33342 and ethyleneglycol-bis(β-
aminoethylether)tetraacetic acid (EGTA) were purchased from 
Sigma (St. Louis, MO). CDP-Star
TM
 (a chemiluminescent substrate 
for alkaline phosphatase) was purchased from Boehringer 
Mannheim (Mannheim, Germany), while bicinchoninic acid (BCA) 




Cell culture and 2-BP treatment  
 
Mouse embryonic stem cells (ESC-B5) were cultured in DMEM 
supplemented with 20% heat-inactivated fetal bovine serum, 100 
U/ml penicillin and 100 μg/ml streptomycin. Cells were plated on 60 
mm culture dishes, and 2-BP treatments were performed the 
following day. For 2-BP treatment, cells were incubated in a 
medium containing various concentrations of 2-BP at 37°C in a CO2 
incubator for 24 h. Cells were then washed twice with ice-cold PBS 
and lysed on ice for 10 min in 400 μl lysis buffer (20 mM Tris-HCl, 
pH 7.4, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 1 mM 
benzamidine, 1 mM phenylmethylsulfonyl fluoride, 50 mM NaF, 20 
μM sodium pyrophosphate and 1 mM sodium orthovanadate). Cell 
lysates were sonicated on ice for 3 × 10 s followed by centrifugation 
at 15,000 × g for 20 min at 4°C. The supernatants were used as cell 
extracts. 
 






Cell survival was monitored using the MTT (3-[4,5-dimethylthiazol-
2-yl] -2,5-diphenyltetrazolium bromide) test. Briefly, cells were 
treated with the indicated concentrations of 2-BP for 24 h, and then 
treated with 100 μL of 0.45 g/L MTT solution. The cells were 
incubated at 37°C for 60 min to allow color development, and then 
100 μL of 20% sodium dodecyl sulphate (SDS) in DMF:H2O (1:1) 
solution was added to each well to stop the reaction. The plates 
were incubated overnight at 37°C for solubilization of formazan 
products, and spectrophotometric data were measured using an 
enzyme linked immunosorbent assay (ELISA) reader at a 
wavelength of 570 nm. 
 
 
Assessment of necrosis and apoptosis 
 
Oligonucleosomal DNA fragmentation (a hallmark of apoptosis) was 
measured using the cell death detection ELISA
plus
 kit (Roche 
Molecular Biochemicals, Mannheim, Germany). Cells (1×10
5
) were 
treated with or without the indicated concentrations of 2-BP at 37°C 
for 24 h, the procedures were performed according to the 
manufacturer’s protocol, and spectrophotometric data were 
obtained using an ELISA reader at 405 nm. In addition, cells were 
incubated with propidium iodide (1 μg/ml) and Hoechst 33342 (2 
μg/ml) at room temperature for 10 min, and fluorescent microscopy 
was used to identify the percentage of propidium iodide-
impermeable cells having condensed/fragmented nuclei (apoptotic) 
and the percentage of propidium iodide-permeable cells (necrotic). 
In each experiment, 8-10 independent fields (~500-800 nuclei in 
total) were counted per condition. The activity of lactate 
dehydrogenase (LDH) present in the culture medium was evaluated 
as an additional index of necrosis, as previously described (Behl et 
al., 1994; Chan and Chang, 2006; Wu and Chan, 2007). Briefly, 
cells (5×10
4
) were cultured in 96-well microtiter plates (100 μL 
medium/well), LDH activity was assayed using, and the absorption 
values at 490 nm were determined with an ELISA reader, according 
to the manufacturer’s instructions (Promega, Madison, WI). Blanks 





ROS were measured in arbitrary units using 2’,7’-
dichlorofluorescein diacetate (DCF-DA) or dihydrorhodamine 123 
(DHR 123) dye. Cells (1.0×10
6
) were incubated in 50 μL PBS 
containing 20 μM DCF-DA or DHR123 for 1 h at 37°C, and relative 
ROS units were determined using a fluorescence ELISA reader 
(excitation 485 nm, emission 530 nm). An aliquot of the cell 
suspension was lysed, the protein concentration was determined, 










]i was detected with Fluo-3 AM fluorescence dye, using a 
modification of the previously reported method (Aoshima et al., 
1997; Lu et al., 2006). Briefly, cells were co-treated with 2-BP, 
harvested and washed, and then loaded with 6 μM Fluo-3 AM in 
standard medium (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 5.6 mM 
glucose, 1.5 mM CaCl2, and 20 mM Hepes, pH of 7.4). After 30 min, 
the cells were washed 3 times with PBS and then resuspended in 
standard medium or Ca
2+
-free standard medium. The fluorescence 
intensity of Fluo-3 was determined using a fluorescence 
spectrophotometer (Hitachi, F-2000; excitation at 490 nm, emission 





Detection of intracellular NO content 
 
The  DAF-2DA  fluorescence  dye  was  used  to  detect intracellular 
NO, according to a modification of the previously reported method 
(Lu et al., 2006; Nakatsubo et al., 1998). Briefly, treated or control 
cells were collected and washed, and then incubated with 3 μM 
DAF-2DA. After 60 min, the cells were washed three times with 
PBS and the fluorescence intensity was measured by a 
fluorescence spectrophotometer (Hitachi, F-2000; excitation at 485 
nm, emission at 515 nm). 
 
 
Caspase activity assays 
 
Caspase-9 activity was assayed using the Colorimetric Caspase-9 
Assay Kit (Calbiochem, CA). Caspase-3 activity was measured 
using the Z-DEVD-AFC fluorogenic substrate, as previously 
described (Chan et al., 2003; Hsieh et al., 2003). 
 
 
Real-time RT-PCR assay 
 
Total RNA was extracted with the TRIzol reagent (Life 
Technologies) and purified with an RNeasy Mini kit (Qiagen) 
according to the manufacturers’ protocols. Real-time PCR was 
carried out with an ABI 7000 Prism Sequence Detection System 
(Applied Biosystems). The β-actin mRNA levels were quantified as 
an endogenous control, and used for normalization. The primers 
used for PCR were as follows: p53, 5′-CCC ATC CTC ACC ATC 
ATC AC-3′ and 5′-GTC AGT GGG GAA CAA GAA GTG-3′; p21, 5′-
GCC GAA GTC AGT TCC TTG TGG A-3′ and 5′-GTG GGC GGA 





Lipofectamine was used to transfect mononuclear cells with 150 nM 
of siRNA for targeting against p53 (5'-
GACUCCAGUGGUAAUCUACTT-3'; sip53) or a scrambled control 
duplex (5'-GCGCGCUUUGUAGGAUUCG-3'; siScr). Twenty-four 
hours post-transfection, fresh culture medium was added, and the 
cells were treated with or without 10 μM 2-BP for another 24 h.  
 
 
Embryoid body formation 
 
Embryoid bodies were generated as previously described (Chan, 
2006). Briefly, ESC-B5 cells were dissociated with trypsin-EDTA 
(0.25%) and cultured in leukemia inhibitory factor (LIF)-free stem 
cell medium to induce differentiation. Cell suspension liquid cultures 
(<10
4
 cells/ml) were dispensed to 10 cm petri dishes (10 ml per 
dish). EB formation was initiated in hanging drop cultures prepared 
with 10-μL droplets, each containing an appropriate number (~100) 
of ESC-B5 cells. The ESC-B5 cells were allowed to aggregate in 






Data were analyzed using one-way ANOVA, and differences were 
evaluated using a two tailed Student’s t-test and analysis of 





Cytotoxic effects of 2-BP on ESC-B5 cells 
 
To assess the potential cytotoxicity of 2-BP, the MTT
 






Figure 1.  Effects of 2-BP on ESC-B5 cells: ESC-B5 cells were incubated with 0–10 μM 2-BP for 24 h. (A) Cell viability was 
determined using the MTT assay. (B and C) Apoptosis was detected with a cell death detection ELISA kit (B), followed by 
staining with propidium iodide and Hoechst 33342 (C). (D) Necrosis was further assessed in terms of LDH activity in the 
culture medium, and the data are expressed as a percentage of the maximal level (Max) of LDH activity determined after total 
cell lysis. Values are presented as means ± SEM of eight determinations. *, P < 0.05; **, P < 0.01; ***, P < 0.001 versus the 




assay was used to examine the viability of ESC-B5 cells 
incubated in medium containing 0 to 10 µM 2-BP for 24 h. 
Results revealed that the viability of treated ESC-B5 cells 
was dose-dependently decreased by approximately 23 to 
46% at concentrations higher than 5 µM 2-BP (Figure 
1A). We next used a TUNEL ELISA kit to examine 
apoptosis, in an effort to determine the mode of 2-BP-
induced cell death. Notably, 10 μM 2-BP induced a 4.9-
fold increase in TUNEL positivity, compared with 
untreated cells (Figure 1B). The percentages of apoptotic 
and necrotic cells were further evaluated by staining with 
propidium iodide and Hoechst 33342. As shown in Figure 
1C, the proportion of apoptotic cells was significantly 
increased following treatment with 5 to 10 μM 2-BP. 
However, no necrotic cells were identified in the 2-BP-
treated group (Figures 1C and 1D). Our findings indicate 
that 2-BP induces apoptosis, but not necrosis, at 
concentrations greater than 5 μM in ESC-B5 cells. 
 
 
ROS levels increase in ESC-B5 cells treated with 2-
BP 
 
In view of our previous finding that numerous chemical  
stimuli trigger apoptosis via ROS generation (Chan, 
2007; Huang et al., 2007), DCF-DA and DHR 123 were 
used to examine ROS formation in ESC-B5 cells treated 
with 2-BP. The results revealed that 2-BP (5–10 μM) 
stimulated ROS generation about 2.8 to 5.3-fold, 
compared with the untreated control group (Figure 2A). 
Notably, pretreatment with N-acetyl cysteine (NAC), a 
commonly used ROS scavenger, effectively prevented 
ROS generation in the presence of 5 to 10 μM 2-BP 
(Figure 2B). These results clearly indicate that 2-BP 
triggers apoptosis of ESC-B5 cells via ROS generation.
 






Figure 2. 2-BP promotes oxidative stress in ESC-B5 cells: (A) ESC-B5 cells were treated with 0 to 10 μM 2-BP for 24 h and ROS 
generation was assayed using DCF-DA (20 μM) or dihydrorhodamine 123 (DHR 123; 20 μM). (B) ESC-B5 cells were pre-
incubated with N-acetyl cysteine (NAC; 300 μM) for 30 min, followed by treatment with or without 2-BP, as indicated. ROS 
generation was assayed using DCF-DA. Data are representative of eight independent experiments. ***, P < 0.001 versus the 




Changes in intracellular Ca
2+
 concentrations and NO 




]i in 2-BP-treated ESC-B5 cells were 
detected using the fluorescent dye, Fluo-3AM. Treatment 
with 5 to 10 μM 2-BP elicited an increase in [Ca
2+
]i 





free culture media displayed a ~3-fold increase in [Ca
2+
]i 
following treatment with 10 μM 2-BP (Figure 3A). These 
findings indicate that the 2-BP-induced increase in [Ca
2+
]I 
is primarily due to the release of internal Ca
2+
, likely from 
the endoplasmic reticulum, mitochondria, nucleus and/or 
calcium-binding proteins (Figure 3A).  
PTIO, an inhibitor of NOS and a scavenger of NO, and 
L-NMMA, an inhibitor of NO synthase (NOS), had little 
effect on the [Ca
2+
]i increase induced by 2-BP, but 
pretreatment with NAC significantly suppressed this 
increase (Figure 3B). Thus, it seems that the 2-BP-
induced increase in [Ca
2+
]i is regulated by ROS but not 
NO. We further used the NO-sensitive dye, DAF-2DA, to 
measure intracellular NO generation during 2-BP-induced 
apoptosis. The results revealed that intracellular NO 
levels were increased in ESC-B5 cells treated with 10 μM 
2-BP (Figure 3C), but this increase was prevented by 
pretreatment of cells with the NOS inhibitor, L-NMMA 
(Figure 3C), or with 500 μM EGTA (a Ca
2+
 chelator) 
(Figure 3C).  
Based on these findings, it was proposed that 
intracellular Ca
2+
 levels play an important role in the NOS 
activation and NO increase observed in 2-BP-treated 
ESC-B5 cells. Furthermore, our results clearly indicate 
that 2-BP triggers apoptosis of ESC-B5 cells via ROS 
generation and further demonstrate that NAC rescues the 
viability of 2-BP-treated cells. 
PTIO inhibits mitochondrial membrane potential 
(MMP) changes and caspase activation during 2-BP-
induced cell apoptosis 
 
Next, we analyzed changes in MMP, a major apoptotic 
event during mitochondria-mediated apoptosis. Uptake of 
DiOC6(3) and TMRE into the mitochondria of ESC-B5 
cells was observed following treatment with 10 μM 2-BP, 
indicating that there was a significant loss of MMP (Figure 
4A). In addition, we monitored the activations of caspase-
9 and -3, which are involved in the mitochondria-
mediated apoptotic pathways, and found that the 
treatment of ESC-B5 cells with 10 μM 2-BP stimulated 
caspase-9 (Figure 4B) and -3 (Figure 4C) activities. 
Importantly, the 2-BP-induced MMP loss and caspase 
activation were significantly inhibited when cells were 
pretreated with 20 μM PTIO prior to with the application 
of 10 μM 2-BP (Figures 4A to 4C). These results indicate 
that the NO level may act as an upstream regulator of 
MMP changes and caspase-9 and -3 activation during the 
2-BP-induced apoptosis of ESC-B5 cells.  
 
 
Changes in mRNA levels following 2-BP treatment of 
ESC-B5 cells 
 
Data from real-time RT-PCR analyses revealed 
significant upregulations of p53 and p21 mRNA levels in 
ESC-B5 cells treated with 10 μM 2-BP. These responses 
were blocked by pretreatment with NAC or PTIO (Figures 
5A and B).  
 
 
Treatment of ESC-B5 cells with p53 siRNA blocks 2-
BP-induced apoptosis 
 
To   further   determine   the   roles   of  p53  and  p21  in   
 






Figure 3. 2-BP stimulates changes in the intracellular calcium and NO contents of ESC-B5 cells: (A) ESC-B5 cells were incubated 
with 0 to 10 μM 2-BP for 24 h. Intracellular Fluo-3 fluorescence intensity was measured in the presence/absence of extracellular 
Ca
2+
. (B) Changes in intracellular Ca
2+
 level upon treatment with 10 μM 2-BP, and the effects of ROS and NO inhibitors (NAC, 300 
μM; L-NMMA, 400 μM; PTIO, 20 μM) were measured. (C) ESC-B5 cells were pretreated with L-NMMA (400 μM) or EGTA (500 μM) 
for 30 min, followed by incubation with or without 10 μM 2-BP. Intracellular NO generation was measured using the fluorescent dye, 
DAF-2DA. Data are presented as a percentage of the control group. ***, P < 0.001 versus the untreated control group; #, P < 0.001 




Effects of 2-BP on the development and 
differentiation of ESC-B5 cells in vitro 
 
To further determine the effects of 2-BP on early 
embryonic development in a stem cell assay model, we 
incubated cells in the presence or absence of 2-BP and 
assessed their ability to form embryoid bodies in vitro. 
Embryoid body formation was not affected by 2-BP at 
concentrations of less than 5 μM, but the application of 
10 μM 2-BP significantly decreased embryoid body 
formation (Figure 7). These findings show that low doses 
of 2-BP (< 5 μM) have no injury effects on ESC-B5 cells, 
whereas higher concentrations (5 to 10 μM) trigger 




Oxidative stress stimulates several cell responses, 
including apoptosis (Khan et al., 2013; Rhee et al., 2013). 
A previous study demonstrated a significant decrease in 
superoxide dismutase (SOD) and an increase in 
glutathione peroxidase (GSH-PX) activity in Leydig cells 
treated with 0.10 and 1.00 mM 2-BP (Wu et al., 2002), 
suggesting that 2-BP impaired the antioxidant defenses in 
Leydig cells. The same study further demonstrated that 2-
BP also induces DNA damage and enhances lipid 
peroxidation in cultured Leydig cells (Wu et al., 2002). 
Here, it was demonstrated that 2-BP directly induced 
oxidative stress in ESC-B5 cells (Figure 2), and that 
pretreatment with antioxidants effectively prevented ROS- 
 






Figure 4. MMP alterations and activation of caspase-9 and -3 following 2-BP treatment of ESC-B5 cells. ESC-B5 cells were 
pretreated with PTIO (20 μM) for 1 h, and treated with or without 10 μM 2-BP for a further 24 h. (A) MMP changes were 
analyzed using 40 nM DiOC6(3) or 1 μM TMRE. (B) Caspase-9 activity was assayed using a Colorimetric Caspase-9 Assay 
kit. (C) Cell extracts (60 μg) were analyzed for caspase-3 activity using Z-DEVD-AFC as the substrate. ***, P < 0.001 versus 






Figure 5. Effects of NAC and PTIO on p53 and p21 mRNA levels: ESC-B5 cells were pre-incubated with or without NAC (300 
μM) and PTIO (20 μM) for 1 h, followed by treatment with 10 μM 2-BP for another 24 h. The mRNA levels of p53 (A) and p21 
(B) were analyzed using real-time PCR. Values are representative of eight determinations. ***, P < 0.001 versus the untreated 
control group; #, P < 0.001 versus the 2-BP-treated group. 
 






Figure 6. Knockdown of p53 protects ESC-B5 cells against 2-BP-induced apoptosis: ESC-B5 cells were transfected with 
siRNA targeting p53, incubated for 24 h, and treated with 10 μM 2-BP for a further 24 h. (A) The mRNA levels of p53 and p21 
were analyzed using real-time PCR. (B) Apoptosis was measured as described in Figure 1. ***, P < 0.001 versus the untreated 






Figure 7. Effects of 2-BP on differentiation of ESC-B5 cells: ESC-B5 cells 
were incubated with or without the indicated concentrations of 2-BP for 24 
h. Cells were dissociated with trypsin-EDTA, and cultured in medium 
without LIF to induce differentiation. Embryoid bodies were formed with the 
hanging drop method, as described in the Materials and Methods section. 





mediated 2-BP-induced apoptotic biochemical changes 
(Figures 2 and 3). ROS is an important upstream 
regulator of the apoptotic cascade in various mammalian 
cells (Webster, 2012). These results, coupled with our 
findings, strongly indicate that oxidative injury plays a 
pivotal role in 2-BP-induced apoptosis. However, the 
mechanisms underlying 2-BP-triggered ROS generation 
remain to be determined.  
The intracellular calcium level plays an important role in  
regulating cell death (Dinicola et al., 2013). A previous 
study by our group showed that increases in intracellular 
calcium levels were involved in cell apoptosis triggered 
by specific chemical compounds (Chan, 2008; Hsieh and 
Chan, 2009). Furthermore, intracellular ROS is known to 
act as an upstream regulator of calcium levels and the 
induction  of  apoptosis  (Chan,  2008; Hsieh  and  Chan,  
 




2009). This study was meant to determine whether 2-BP 
induces apoptosis via an increase in intracellular calcium. 
Notably, an increase in [Ca
2+
]i following 2-BP treatment 
was observed, which shows that this could be largely 
attributed to the release of internal Ca
2+ 
from storage 
organelles (Figures 3A and B). This increase was 
significantly blocked by NAC (Figure 3B), indicating that 
ROS generation is responsible for increasing the 
intracellular calcium concentration in 2-BP-treated ESC-
B5 cells.     
NO, which is an endogenous product of NADPH, O2 
and L-arginine catalysis by NOS, is involved in apoptosis 
triggered by several types of stimuli (Chan, 2008; Hsieh 
and Chan, 2009; Lu et al., 2006; Nazarewicz et al., 
2007). The regulatory actions of NO on the mitochondrial 
apoptotic signaling pathways have been well 
documented. Additionally, previous studies have shown 
that tamoxifen and co-treatment with methylglyoxal and 
high glucose increase the intramitochondrial Ca
2+
 
concentration, stimulating mitochondrial NO synthase 
activity and NO production in rat livers, human breast 
cancer MCF-7 cells, and human mononuclear cells 
(Chan, 2008; Hsieh and Chan, 2009; Nazarewicz et al., 
2007). In the present study, we observed NO generation 
following 2-BP treatment of ESC-B5 cells, with ~3.3-fold 
higher intracellular NO levels in treated cells versus 
untreated controls (Figure 3C). Pretreatment with EGTA 
substantially prevented this increase in intracellular NO 
(Figure 3C), indicating that NO production in 2-BP-treated 
ESC-B5 cells is dependent on the intracellular calcium 
concentration. The regulatory role of NO in apoptosis is 
complex, and NO-mediated apoptotic effects are 
modulated via different mechanisms in distinct cell types 
(Chan, 2008; Hsieh and Chan, 2009; Li and Wogan, 
2005; Rao, 2004). For instance, NOS substrates or NO 
donors inhibit apoptosis induced by photodynamic 
treatment in CCRF-CEM cells (Gomes et al., 2002), and 
an NOS inhibitor was shown to suppress the high 
glucose and methylglyoxal-stimulated mitochondria-de-
pendent apoptotic pathway (Hsieh and Chan, 2009).  
Importantly, it was discovered that PTIO attenuated the 
loss of mitochondrial membrane potential (MMP) and 
suppressed caspase activation in the system (Figure 4), 
suggesting that NO is an important mediator of apoptosis 
in 2-BP-treated ESC-B5 cells. 
NO-mediated apoptotic processes are associated with 
p53 gene activation, which is essential for regulation of 
the cell cycle and/or apoptotic signaling occurring through 
p21
Waf1/Cip1
 or Bax (Li et al., 2004; Okada and Mak, 2004). 
Moreover, a previous study by our group revealed apop-
totic signaling pathway-induced increases in p53 and p21 
expression levels in human mononuclear cells following 
co-treatment with high glucose and methyl-glyoxal (Hsieh 
and Chan, 2009). Here, we observed up regulation of 
both p53 and p21 mRNA following treatment with 2-BP, 





with PTIO and NAC (Figure 5). The p53 pro-tein, an 
expression product of the p53 tumor suppressor gene, 
prevents the proliferation of cells with damaged DNA. 
More specifically, damaged DNA triggers the activation of 
ATM kinase, which catalyzes the phosphorylation of p53 
proteins. Accumulation of phosphorylated p53 proteins in 
DNA-damaged cells activates two types of events: cell 
cycle arrest and apoptosis. The p53 protein also acts a 
transcription factor that can activate specific genes, 
including p21. The p21 protein, a member of the Cdk 
inhibitor family, blocks activation of the Cdk-cyclin 
complex, leading to cell cycle arrest. The p53 protein 
additionally activates genes encoding proteins that trigger 
cell apoptotic processes through binding and inactivating 
the apoptosis inhibitor, Bcl2.  
Finally, p53 plays an important role in the self-renewal 
of ESCs and is involved in cell differentiation (Lin et al., 
2005; Meletis et al., 2006). A previous study reported 
higher p53 protein levels in embryonic cells compared to 
differentiated cells (Sabapathy et al., 1997). Moreover, a 
recent report showed that p53 largely localizes to the 
cytoplasm of ESCs (Aladjem et al., 1998; Solozobova et 
al., 2009), but shows a mainly nuclear or perinuclear 
localization in many other cell lines (Shaulsky et al., 
1990). These results highlight the important regulatory 
role of p53 in the differentiation of mouse ESCs. Here, we 
showed that 2-BP induces the expression of p53 (Fig. 
5A), and siRNA-mediated knockdown of p53 mRNA 
prevented the 2-BP-induced the upregulation of p21 
mRNA expression and suppressed subsequent apoptosis 
(Figure 6A and B). Our data collectively indicate that p53 
and p21 are activated by 2-BP treatment and play a 
critical regulatory role during 2-BP-induced apoptosis of 
ESC-B5 cells, but are not involved in regulating the 
differentiation potential of these cells. We hypothesize 
that in 2-BP-treated ESC-B5 cells, ROS generation 
triggers DNA damage, thereby activating p53 and 
downstream apoptotic signaling cascades.  
These results collectively demonstrate that 2-BP has 
no injury effects on ESC-B5 cells at doses lower than 5 
μM, but induces apoptosis at concentrations greater than 
5 μM. Moreover, 2-BP directly triggers ROS generation, 
which in turn induces the release of calcium from 
intracellular storage organelles, increasing intracellular 
Ca
2+
 concentrations and stimulating NO production. 
Pretreatment with NAC or PTIO blocks the 2-BP-induced 
upregulation of critical genes and rescues cell viability. 
Based on these data, we propose that both intracellular 
ROS and NO play critical roles in the 2-BP-induced 
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